Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | GW441756 |
| Synonyms | |
| Therapy Description |
GW441756 is a selective inhibitor of TrkA and blocks cellular processes caused by TrkA overexpression (PMID: 23319303, PMID: 31651704). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| GW441756 | TrkA Receptor Inhibitor 8 | GW441756 is a selective inhibitor of TrkA and blocks cellular processes caused by TrkA overexpression (PMID: 23319303, PMID: 31651704). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| NTRK1 over exp | neuroblastoma | sensitive | GW441756 | Preclinical | Actionable | In a preclinical study, GW441756, a TrkA inhibitor, blocked tyrosine phosphorylation of ERK and JNK induced by TrkA over expression in neuroblastoma cells (PMID: 23319303). | 23319303 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|